Blastic plasmacytoid dendritic cell neoplasm

Blastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell lymphoma. Treatment is with induction using a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Rai, Manoj Ponadka, Bedi, Prabhjot Singh, Kandola, Samanjit Kaur, Kavuturu, Shilpa, Singhal, Rashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889251/
https://www.ncbi.nlm.nih.gov/pubmed/29636962
http://dx.doi.org/10.1002/ccr3.1457
_version_ 1783312670361911296
author Rai, Manoj Ponadka
Bedi, Prabhjot Singh
Kandola, Samanjit Kaur
Kavuturu, Shilpa
Singhal, Rashi
author_facet Rai, Manoj Ponadka
Bedi, Prabhjot Singh
Kandola, Samanjit Kaur
Kavuturu, Shilpa
Singhal, Rashi
author_sort Rai, Manoj Ponadka
collection PubMed
description Blastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell lymphoma. Treatment is with induction using a regimen utilized for leukemia. Allogeneic hematopoietic stem cell transplantation is recommended for those who achieve remission following induction.
format Online
Article
Text
id pubmed-5889251
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58892512018-04-10 Blastic plasmacytoid dendritic cell neoplasm Rai, Manoj Ponadka Bedi, Prabhjot Singh Kandola, Samanjit Kaur Kavuturu, Shilpa Singhal, Rashi Clin Case Rep Clinical Images Blastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell lymphoma. Treatment is with induction using a regimen utilized for leukemia. Allogeneic hematopoietic stem cell transplantation is recommended for those who achieve remission following induction. John Wiley and Sons Inc. 2018-03-04 /pmc/articles/PMC5889251/ /pubmed/29636962 http://dx.doi.org/10.1002/ccr3.1457 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Rai, Manoj Ponadka
Bedi, Prabhjot Singh
Kandola, Samanjit Kaur
Kavuturu, Shilpa
Singhal, Rashi
Blastic plasmacytoid dendritic cell neoplasm
title Blastic plasmacytoid dendritic cell neoplasm
title_full Blastic plasmacytoid dendritic cell neoplasm
title_fullStr Blastic plasmacytoid dendritic cell neoplasm
title_full_unstemmed Blastic plasmacytoid dendritic cell neoplasm
title_short Blastic plasmacytoid dendritic cell neoplasm
title_sort blastic plasmacytoid dendritic cell neoplasm
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889251/
https://www.ncbi.nlm.nih.gov/pubmed/29636962
http://dx.doi.org/10.1002/ccr3.1457
work_keys_str_mv AT raimanojponadka blasticplasmacytoiddendriticcellneoplasm
AT bediprabhjotsingh blasticplasmacytoiddendriticcellneoplasm
AT kandolasamanjitkaur blasticplasmacytoiddendriticcellneoplasm
AT kavuturushilpa blasticplasmacytoiddendriticcellneoplasm
AT singhalrashi blasticplasmacytoiddendriticcellneoplasm

Ejemplares similares